Vedanta Biosciences

Vedanta Biosciences

Vedanta Biosciences

Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome.
Raised
$95.5M
Follow us
Alexa global traffic share
Twitter followers
13 May 2019
$18,500,000
Venture capital (Series C)
27 Dec 2018
$27,000,000
Venture capital (Series C)

Vedanta Biosciences Raises $27 Million Series C Financing

StartupWorld
+2